FR2426470A1 - IMMUNOBIOTHERAPIC DRUG AGAINST INFECTIOUS DISEASES OF THE RESPIRATORY TRACT - Google Patents

IMMUNOBIOTHERAPIC DRUG AGAINST INFECTIOUS DISEASES OF THE RESPIRATORY TRACT

Info

Publication number
FR2426470A1
FR2426470A1 FR7913157A FR7913157A FR2426470A1 FR 2426470 A1 FR2426470 A1 FR 2426470A1 FR 7913157 A FR7913157 A FR 7913157A FR 7913157 A FR7913157 A FR 7913157A FR 2426470 A1 FR2426470 A1 FR 2426470A1
Authority
FR
France
Prior art keywords
nctc
respiratory tract
immunobiotherapic
infectious diseases
against infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913157A
Other languages
French (fr)
Other versions
FR2426470B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OM LAB SA
Original Assignee
OM LAB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4299594&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2426470(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by OM LAB SA filed Critical OM LAB SA
Publication of FR2426470A1 publication Critical patent/FR2426470A1/en
Application granted granted Critical
Publication of FR2426470B1 publication Critical patent/FR2426470B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Médicament immunobiothérapique contenant comme principe actif un lysat bactérien provenant d'au moins une des souches suivantes : Staphylococcus aureus I-049, I-050, I-051, I-052, I-053, I-054 Streptococcus viridans I-046, I-047, I-048 Neisseria catarrhalis 1-045 et d'au moins une des souches suivantes : Hemophilus influenzae sérotype b NCTC 8467 Diplococcus pneumoniae sérotypes 1, 2, 3 et 47 NCTC 7465, 7466, 7978, 10319 Klebsiella pneumoniae NCTC 204, 5056 Klebsialla ozaenae NCTC 5050 Streptococcus pyogenes sérogroupe A NCTC 8191 Neisseria catarrhalis NCTC 3622, 3625. Application au traitement des maladies des voies respiratoires.Immunobiotherapy medicinal product containing as active principle a bacterial lysate obtained from at least one of the following strains: Staphylococcus aureus I-049, I-050, I-051, I-052, I-053, I-054 Streptococcus viridans I-046, I-047, I-048 Neisseria catarrhalis 1-045 and at least one of the following strains: Hemophilus influenzae serotype b NCTC 8467 Diplococcus pneumoniae serotypes 1, 2, 3 and 47 NCTC 7465, 7466, 7978, 10319 Klebsiella pneumoniae NCTC 204 , 5056 Klebsialla ozaenae NCTC 5050 Streptococcus pyogenes serogroup A NCTC 8191 Neisseria catarrhalis NCTC 3622, 3625. Application to the treatment of diseases of the respiratory tract.

FR7913157A 1978-05-26 1979-05-23 IMMUNOBIOTHERAPIC DRUG AGAINST INFECTIOUS DISEASES OF THE RESPIRATORY TRACT Granted FR2426470A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH580578A CH633188A5 (en) 1978-05-26 1978-05-26 MEDICINE FOR INFECTIOUS DISEASES OF THE RESPIRATORY TRACT.

Publications (2)

Publication Number Publication Date
FR2426470A1 true FR2426470A1 (en) 1979-12-21
FR2426470B1 FR2426470B1 (en) 1983-08-05

Family

ID=4299594

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913157A Granted FR2426470A1 (en) 1978-05-26 1979-05-23 IMMUNOBIOTHERAPIC DRUG AGAINST INFECTIOUS DISEASES OF THE RESPIRATORY TRACT

Country Status (15)

Country Link
JP (1) JPS54154509A (en)
BE (1) BE876164A (en)
CH (1) CH633188A5 (en)
CS (1) CS222673B2 (en)
DD (1) DD143729A5 (en)
DE (1) DE2917730C2 (en)
ES (1) ES480448A1 (en)
FR (1) FR2426470A1 (en)
GB (1) GB2021415B (en)
HU (1) HU180005B (en)
IT (1) IT1116213B (en)
PL (1) PL126416B1 (en)
PT (1) PT69674A (en)
RO (1) RO78451A (en)
YU (1) YU41864B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707A1 (en) * 1983-08-17 1985-02-22 Lipha IMMUNOMODULATOR MEDICINE OF BIOLOGICAL ORIGIN AND PROCESS FOR PREPARING THE SAME

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH680045A5 (en) * 1990-02-16 1992-06-15 Om Lab Sa
CH685498A5 (en) * 1992-02-14 1995-07-31 Om Lab Sa macromolecules bacterial extract, process for its preparation and pharmaceutical composition containing this extract.
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same
SE511648C2 (en) * 1998-04-17 1999-11-01 Bacterum Ab Streptococcus preparations for the treatment of ear inflammation
PL2114421T3 (en) * 2007-03-05 2018-07-31 Om Pharma Bacterial extract for respiratory disorders and proces for its preparation
CN104922330A (en) * 2015-07-15 2015-09-23 龚灿锋 Traditional Chinese medicine for treating amygdalitis

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE543985A (en) *
FR2892M (en) * 1963-07-25 1964-11-02 Inst Rech Scient Substances with immunizing and desensitizing action.
FR6513M (en) * 1967-07-12 1968-12-02
FR7010M (en) * 1967-11-10 1969-06-02
FR7461M (en) * 1968-06-19 1970-01-05
FR2043475A1 (en) * 1969-05-20 1971-02-19 Cassenne Lab Sa
FR2171907A2 (en) * 1972-02-15 1973-09-28 Cassenne Lab Sa
FR2253499A1 (en) * 1973-12-10 1975-07-04 Fabre Sa Pierre
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
FR2283697A1 (en) * 1974-09-06 1976-04-02 Irceba NASAL COMPOSITION CONTAINING ANTIGENS OF BACTERIAL ORIGIN
FR2307542A1 (en) * 1975-04-14 1976-11-12 Synthelabo Immuno-stimulant preparations for human and veterinary use - contg. a mixture of inactivated and lysed bacterial cells
FR2315944A1 (en) * 1975-07-04 1977-01-28 Tournade Francois Non specific immunitary stimulants - contg. separately protein and lipid extracts from human mucosa microorganisms

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE543985A (en) *
FR2892M (en) * 1963-07-25 1964-11-02 Inst Rech Scient Substances with immunizing and desensitizing action.
FR6513M (en) * 1967-07-12 1968-12-02
FR7010M (en) * 1967-11-10 1969-06-02
FR7461M (en) * 1968-06-19 1970-01-05
FR2043475A1 (en) * 1969-05-20 1971-02-19 Cassenne Lab Sa
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
FR2171907A2 (en) * 1972-02-15 1973-09-28 Cassenne Lab Sa
FR2253499A1 (en) * 1973-12-10 1975-07-04 Fabre Sa Pierre
FR2283697A1 (en) * 1974-09-06 1976-04-02 Irceba NASAL COMPOSITION CONTAINING ANTIGENS OF BACTERIAL ORIGIN
FR2307542A1 (en) * 1975-04-14 1976-11-12 Synthelabo Immuno-stimulant preparations for human and veterinary use - contg. a mixture of inactivated and lysed bacterial cells
FR2315944A1 (en) * 1975-07-04 1977-01-28 Tournade Francois Non specific immunitary stimulants - contg. separately protein and lipid extracts from human mucosa microorganisms

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707A1 (en) * 1983-08-17 1985-02-22 Lipha IMMUNOMODULATOR MEDICINE OF BIOLOGICAL ORIGIN AND PROCESS FOR PREPARING THE SAME
EP0139551A2 (en) * 1983-08-17 1985-05-02 Lipha, Lyonnaise Industrielle Pharmaceutique Immunomodulating medicine of biological origin, and process for preparing it
EP0139551A3 (en) * 1983-08-17 1985-07-10 Lipha, Lyonnaise Industrielle Pharmaceutique Immunomodulating medicine of biological origin, and process for preparing it

Also Published As

Publication number Publication date
HU180005B (en) 1983-01-28
JPS54154509A (en) 1979-12-05
DE2917730C2 (en) 1986-04-03
YU41864B (en) 1988-02-29
IT7949157A0 (en) 1979-05-24
GB2021415A (en) 1979-12-05
PL215824A1 (en) 1980-02-11
PT69674A (en) 1979-06-01
BE876164A (en) 1979-09-03
CS222673B2 (en) 1983-07-29
YU123679A (en) 1983-04-30
ES480448A1 (en) 1979-12-16
IT1116213B (en) 1986-02-10
DE2917730A1 (en) 1979-11-29
DD143729A5 (en) 1980-09-10
JPS6337770B2 (en) 1988-07-27
RO78451A (en) 1982-02-26
FR2426470B1 (en) 1983-08-05
CH633188A5 (en) 1982-11-30
PL126416B1 (en) 1983-08-31
GB2021415B (en) 1983-03-30

Similar Documents

Publication Publication Date Title
Comber et al. Comparative effects of amoxycillin and ampicillin in the treatment of experimental mouse infections
Woodward et al. In vitro growth inhibition of mastitis pathogens by bovine teat skin normal flora.
FR2426470A1 (en) IMMUNOBIOTHERAPIC DRUG AGAINST INFECTIOUS DISEASES OF THE RESPIRATORY TRACT
Finland The present status of antibiotics in bacterial infections
Shurin et al. Otitis media caused by non-typable, ampicillin-resistant strains of Haemophilus influenzae
CLARKE TOPICAL USE OF SILVER SULPHADIAZINE AND CHLORHEXIDINE IN THW PREVENTION OF INFECTION IN THERMAL INJURIES
Howells et al. Two outbreaks of neonatal skin sepsis caused by Staphylococcus aureus, phage type 71
KR910015306A (en) Drugs for the treatment of dermatitis
FR2376661A1 (en) ANTHELMINTHIC MEDICINAL PRODUCTS CONTAINING ANILINOMETHYLENE-MALONONITRILS AS ACTIVE SUBSTANCES
Ginsburg Streptococcus.
Mellon et al. Therapy of experimental staphylococcus infections with sulfonamide compounds
Barlow Relative Toxicities and Therapeutic Values of Three Chemo-therapeutic Agents of the Sulphonamide Type
KEITH et al. Subacute bacterial endocarditis due to hemolytic streptococci of Lancefield group G
FR2307542A1 (en) Immuno-stimulant preparations for human and veterinary use - contg. a mixture of inactivated and lysed bacterial cells
ES2005057A4 (en) ANTIGENIC BACTERIAL LISATES, A PROCESS FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM.
McFadzean et al. Bacterial endocarditis due to Salmonella sp.(type sendai) with recovery
Moroney Sore throat
FR2143557A1 (en) Antimicrobial n-acyl basic amino acid derivs - useful as antiseptics, preservatives, disinfectants etc
Light et al. Decreased colonization of newborn infants with Staphylococcus aureus 80/81: Cincinnati General Hospital, 1960–1972
Osgood et al. The Mode of Action of Sulfanilamide
Wolman et al. Terramycin in infections in infants and children
Collins et al. The Treatment of Chronic Supprative Otitis Media by the Local Application of Pencillin and Other Drugs
Yow et al. The use of the penicillinase-resistant penicillin in the pneumonias of children
Schuman A concise history of antimicrobial therapy (serendipity and all).
Schauf gentamicin (Deveikis, Schauf, Mizen & Riff, 1977). In summary, there is a clear need for improvement of our understanding of group B streptococcal disease. In the United States, an

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0296, 920526

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0296, 790523

CL Concession to grant licences
CD Change of name or company name